We have prepared a cyclic analog containmg a thiomethylene bridge in place of the disulfide bridge in order to further analyze the importance of a cyclic structure for the biological activity of ct~MSH (u-melanotropin, a-melanocyte stimulating hormone) and to determine if the biological activity of [Cys4,Cysl0J~a-MSH is related to disulfide interchange. The carba analog was based on the highly potent Ac-[Cys4,Cysl0]-a-MSH4_13-NHj fragment analog in which cysteine in residue 4 was replaced by j-rnercaptopropanolc acid (Mpa). This carba analog was slightly less active than the disulfide bridged compound in both ill vitro bioassay systems tested (frog and lizard skin systems). Oxidation of the carba analog to the sulfoxide led to a moderate loss of activity in both assays. We also reduced the 4-13 disulfide-containing compound [Mpa", Cysl0J~a-MSH4_13-NH2and examined the reduced analog for melanotropic activity. It was found that opening of the disulfide led to a large loss of potency. The bis-sulfhydryl compound may have been non-specifically bound to, and/or internalized inside the tissue, but did not show any inhibitory activity.
receptor. This possibility was considered in the proposed mechanism of action of neurohypophyseal hormones', but was ruled out by the syntheses and pharmacological studies of carba-analogs of these hormones'. We thus decided to use this modification in an effort to better understand the mechanism of action of the cyclic melanotropin analogs.
It was known from previous studies!" that a-MSH sensitive receptors could be effectively blocked by compounds containing a free sulfhydryl group. The reduced form of the cyclic [Cys4,Cys'O}Cl-MSH analogs contains two free sulfhydryl groups and might turn out to be either a specific antagonist of Cl-MSH, or an analog with prolonged agonist activity due to strong binding affinity to the receptor. Therefore we also have investigated the biological activities of the reduced form of the potent disulfide group containing analog 11.
Syntheses of carba-analogs can be accomplished by a variety of methods, but the most convenient involves cyclization via an amide bond. This procedure has been used in the synthesis of many biologically active peptides including: oxytocin9.11-14, vasopressin 1S-18, vasotocin!", somatostatin 2 0 -22 , calcitonin 2 3 -2 5 , and the A-chain of insulin?". The cyc1ization was usually carried out using a non-sterically hindered and, if possible, racemization-resistant amino acid. In the case of Cl-MSH, we have shown' that the acetylamino group in position 4 in compound 1 is not required for the full biological activity of Ac-[Cys4,CYS10}Cl-MSH4_13-NI-lz (i.e., substitution of 3-mercaptopropanoic acid for cysteine-4 in analog 11 results in no loss in potency). This prompted us to synthesize an Cl-MSH analog III with S-(2-carboxyethyl)-homocysteine in position 10 and to cyclize it via the ro-carboxyl group of this residue. We synthesized the analog III by solid phase methodology, though we were aware that the cyclization might be accompanied by a large degree of polymerization. Using a p-methylbenzhydrylamine resin of low substitution (0'022 mmol/g], the synthesis was complicated by the need for long reaction times and by difficulties in monitoring the progress of coupling individual amino acids and the cyclization step with Kaiser's test". When using a higher substituted resin (0'36 mmoljg) the cyclization was accompanied by a large degree of polymerization. Individual amino acids were coupled by the dicyclohexy1carbodiimide (DCC)/N-hydroxybenzotriazole (HOBt) method using Boc protected amino acids for the first four residues. After coupling the modified homocysteine residue, the synthesis was continued leaving the «-carboxylic group of S-(2-carboxyethyl)homocysteine free, and utilizing symmetrical anhydrides formed immediately prior to reaction for coupling the remaining amino-acid residues. In order to be sure that dicyclohexylcarbodiimide was not transferred to the reaction mixture we used larger than normal excesses of the Boc-amino acids. Cyclization was achieved on the resin in the presence of dicyclohexy1carbodiimide and N-hydroxybenzotriazole. The cyclic peptide thus obtained was cleaved from the resin and all the protecting groups were removed in liquid hydrogen fluoride containing 10% anisole and 5% 1,2-ethanedithiol 2B • The content of polymers in the crude peptide was estimated by gel filtration. Purification was accomplished by ion exchange chromatography and gel filtration. The homogeneity of the product was determined by a variety of analytical techniques. It has shown that carba-analogs of peptides can be oxidized to their sulfoxide form')g. In the case of oxytocin analogs this usually led to a loss of biological activity29.In order to examine the effect of such an oxidation on cyclic a-MSH analogs, we have prepared the sulfoxide of compound III by oxidation with potassium period ate. The reaction was monitored by high performance liquid chromatography (HPLC) and the resulting product IVwas desalted and purified on a reversed phase HPLC column. Proof of the sulfoxide structure was by fast atom bombardment (FAB) mass spectroscopy; MH+, 1284'8. The carba analog III has slightly lower potency than the corresponding compound II which contains the disulfide bond in both biological assays employed ( Fig. 1 and 2 ).
This could be due to the very pronounced sensitivity of this class of compounds to the size of the intramolecular ring'. The sulfoxide IV was slightly less active in both assays employed ( Fig. 1 and 2 ).
The disulfide bridge of [Mpa"Cys'O}a-MSH 4_13-NH2 (II) was reduced by sodium in liqnid ammonia. This method was used instead of reduction by sulfhydryl groups coutaining compounds even though it was known that it might, possibly, damage the peptide, because we did not want any other sulfhydryl groups present. I. R' = CH,CONH,
and dissolved just prior to biological testing in degassed Ringer solution. The testing was performed simultaneously on the frog and lizard skin assay systems. In both cases reduction of the disulfide led to a very large decrease in potency (in the lizard .skin assay about 1 000 fold and in frog skin assay about 10 000 fold loss in activity).
We did not obser~e any prolongation of activity for this reduced peptide, that is, the biological response was readily reversed by removing the reduced peptide from the bathing medium. In addition when tested at concentrations which displayed no intrinsic biological activity, no inhibition of a-MSH action was observed. In order to prove that we were really dealing with the reduced compound V containing free SI-l groups, we reformed the disulfide via oxidation. By bubbling air through the stock solution of the reduced peptide V we were able to restore 30% of the original activity of [Mpa\Cysl°J-a.MSI-l4_13·NI-l,. Interestingly, bubbling air through a solution of the reduced peptide in the presence of the tissue led to no restoration of the lost activity. It is possible that the peptide in its free sulfhydryl form incorporates itself very rapidly and nonspecifically into the tissue at the concentration used in the assay (10-8 moll-I), such that the concentration of active substance in solution is essentially zero. The observed low activity of the bis-sulfhydryl compound could be due to a small contamination by its oxidized disulfide-containing form, but we have no evidence for this.
The above results clearly show that the high biological activity of cyclic a-MSI-l analogs is not due to disulfide interchange with the receptor, and that the cyclie structure is important mainly for maintaining the proper conformation which favors The small effect of oxidation of the sulfur atom to the sulfoxide group on the activity ofthe carba analog is additional evidence in favor of. the above statements. In addition, the results of these studies can be interpreted lis indicating that the disulfide bridge of the cyclic ex-MSH analogs is not involved in-interaction with the receptor.
EXPERIMENTAL General Methods
Capillary melting points were determined on a Thomas Hoover melting point apparatus and are uncorrected. Thin layer chromatography (TLC) was performed on Silufol plates (Kava lief, Czechoslovakia) using the following solvent systems: A) j-butanol-acctlc acid-water (4: I : 5, upper phase only); B) l-butanoi-acetic acid-pyridine-water (I5: 3 : 10: 12); C) l-butanol-pyridine-acetic acid-water (5: 5: 1 : 4); D) 2-propanol-25% aqueous ammonia-water (3: 1 : 1). Detection was by iodine vapors and ninhydrin. 1 H NMR spectra were recorded on a Perkin--Elmer EM-360L spectrophotometer. Fast atom bombardment mass spectra were obtained on a Varian 311A spectrometer equipped with an Ion Tech Ltd. source with xenon as the bombarding gas. Electrophoresis was performed on Whatman I chromatography paper using an instrument by Gelman and 0·1 moll-1 pyridinium acetate pH 5'3 at a potential drop of 20 V[em, Detection utilized ninhydrin and the chlorination method:
iO . Amino-acid analyses were obtained with a Beckman 120C amino-acid analyzer following hydrolysis for 22 h at 110°C with 4 mol I-I methanesulfonic acid containing 0'2% 3_(2_aminoethyl)indole 3 1 . No corrections were made for destruction of amino acids during hydrolysis. High pressure liquid chromatography (HPLC) was performed on a Spectra-Physics SP-8700 instrument equipped with an SP-8400 detector. using a Vydac CIS column (25 X 0·46 em) for analysis and a Waters ReM column (15 X 0·8 em) for preparative work. We used 0·1 % trifluoroacetic acid as the buffer and acetonitrile as the organic modifier.
N'i-Boc-protected amino acids and amino acid derivatives were prepared using published procedures. Before use, all amino acid derivatives were subjected to the ninhydrin test 2 7 for purity testing. Solvents used for chromatography were purified as previously reported 32. The p-methylbenzhydrylamine resin (0'022 and 0'36 mmcl/g, 1% divinylbenzene cross-linked polystyrene) was prepared by previously reported methods 3 3 . [ A) ji-Methylbenzhydrylamine resin (4 g) was substituted with Bee-valine (0'022 mmol/g). The Boc protecting group was removed with 45% trlfluoroacetic acid containing 2% anisole in dichloromethane in two treatments (30 ml for 2 and 20 min each). Subsequently, Boc-Pro, Boc-Lys(2,4-CI 2Z) and Boc-Hcy(C 1H 4COO-t-Bu) were coupled by standard coupling methods 3 3 using dicycJohexylcarbodiimide (nCC) (11 fold excess) and N-hydroxybenzotriazole (HOBt) (8 fold excess). After removing the protecting groups from the coupled homocysteine derivative, subsequent couplings were performed using symmetrical anhydrides formed by the reacting appropriate amino acid derivative (12 fold excess) with DCC (5 fold excess) in dichloromethane or dimethylformamide at O°C for 3 h. Because of difficulties in following the course of coupling by ninhydrin, all couplings were 22 h long. After the coupling of all amino acids (in order: Boc-Tru(For), Boc-Argf'Tos), Boc-Phe, Boc-Hisf'I'cs), Boc-GlutOfszl) the protecting Collectron Czechoslovak Chern. commun. [Vol. 491 [1984} group from the amino terminal was removed and cyclizationwas performed in the presence of DeC (20 fold excess) and HOBt (20 fold excess). After 40h the resin gave a negative Kaiser's test 27. The peptide resin was washed successively with dichloromethane (3 X 10 ml), ethanol (3 X 10 ml), and dichloromethane (4 X 10 mi), dried ill vacuo (4~lg)andthe peptide was cleaved from half of the resin (2'05 g) in liquid hydrogen fluoride (25 ml), with anisole (3 ml) andI.2--ethanedithiol (l'5 ml) at O"c. After 60 min the liquid hvdrogenjtuorlde.was removed ill vacua and the resin was washed with ethyl acetate (3 x 30ml). The peptide was extracted with 30% acetic acid (3 X 60 rnl). IO~;'; acetic acid (3 X 60 ml}, and water (3x50ml). Lyophilization of the extracts gave 38 mg (66/~) of a powder, which was suspendedIriymlof.O'Ol mol 1-1 ammonium acetate (pl-l 4'5). The mixture was centrifuged and thesupernatanrwas applied to a carboxymethylcellulose cation exchange column (2 x 20 ern). The column was successively eluted with 0·01 mol 1-1 ammonium acetate, pH 4·5 and 0·1 mol 1",",:1 ammonium acetate; pH 6·g (250 ml each). The appropriate peaks were collected (280 nm detection); lyophilized and tested for C(-MSH activity in the lizard skin. Significant activity was found only in one peak; which was further purified by reversed phase HPLC on an Altech C-18 column (25 X 0'46 em) in a gradient of acetonitrile in O·l~~trifluoroacetic acid. A pure compound (1. 3 mg, 1·1%) was-obtained (TLC and HPLC).
B)
A second synthesis was performed on a p-methylbenzhydrylamine resin (2 g) with an amine content of 0'36 mmoljg. For the coupling of the first .four. amino acids (Boc-Valc Boc-Pro, Boc MLys(2,4-CI 2Z), and Boc-Hcy(C 2H 4COO-t-Bu}) we used a four fold excess of the protected amino acids and DCC and a 3'5 fold excess of HOBt. For further couplings symmetrical anhydrides were used, formed from the protected amino acid (in order: Boc-TrprFor), Boc-Argf'Tosj, Boc-Phe, Boc-HisfTos), and Boc-GlufObzl) using an 8 fold excess of an amino acid and a 3'3 fold excess of DCC. The coupling were monitored by Kaiser's test, and the cyclizatlon, complete in 24 h, was performed as outlined in A). Half of the resin was treated with liquid hydrogen fluoride as described in A), and 495 mg of crude peptide was obtained after lyophilization. The amount of high molecular weight products was determined by gel filtration on 5 mg of the crude peptide on a Bie-gel P~4 column (100 X 1·0 em) in 3 moll-1 acetic acid. The Iyophilizate (490 mg) was suspended in 40 ml of 0·01 moll-1 ammonium acetate pH 4·5 buffer, filtered through a Millipore filter (0'2Ilm) and introduced onto a carboxymethylcellulcse column {25 x 2·5 cm).lt was eluted with a discontinuous gradient of 0'01 moll-1 ammonium acetate (p H 4,5, 300 ml), 0·1 moll-1 ammonium acetate (pH 6'8, 300 ml), and 10% acetic acid (300 mh. The fraction eluted at the same volume as [Mpa4,Cysl0]-ClMMSH4_13MNHz was collected, lyophilized and further purified by gel filtration on Bie-Gel P-4 (100 x 1·0 Jm) in I mol 1-1 acetic acid; 13·2 mg (2'4~{) of the purified peptide (HPLC and TLC) was obtaineti. The product, k' = 2·5 (Vydac C M18, acetonltrlfe-n-t X trifluoroacetic acid, I : 4) was oxidized by KI0 4, and this resulted in a new peak on HPLC (k' = I '42) which was isolated. The carba-analog III (4,5 rug) was dissolved in water (200 Ill) and a saturated solution of KIO..:. in water (100 ul) was added. Progress of the reaction was followed by HPLC (Vydac C-18; 25 X X 0·46 em; acetonitrilc-Ovl i~trifluoroacetic acid, 1 : 4). After disappearance of starting compound III, the solution was injected on a Waters C-18 Radial Pak column (10 X 0·8 ern) and peptide was eluted by a gradient of acetonitrile in 0'1/~trifluoroacetic acid (5 to 25% in 20 min; flow rate 4 ml/min). After lyophilization, 1'3 mg of corn pound IV was obtained. Mass spectrum: MH+ 1284'8. [Mpa4,CyslOi::'a-MSH4_1rNHz (II) (3 mgj was dissolved in liquid ammonia (6 ml) and reduced with metallicsodium (until blue color persisted for 30 s). The solution was decolorized with ammonium chloride and lyophilized. The residue was dissolved in degassed Ringer's solution (as a controlcjdegassed Ringer's solution and a~MSH was tested in the bioassay systems with no loss of biological activity) to a final concentration of 10-4 moll-I. Further solution, 10 -6 to to-9 moll-1 were prepared by serial dilution of the 10-6 mol I-1 stock solution. The solutions were used immediately in the bioassays and the results are summarized in Figs 1 and 2 . In order to verify that the solutions actually contained the reduced peptide we tried to reform the disulfide by bubbling air through the solution. By bubbling the stock solution (10- 4 moll-I we were able to restore 30% of the original activity of [Mpa4,CysIO]-a-MSH4_13-MHz' Upon aeration of a solution that was in contact with the lizard skin no restoration of a-MSH activity (in both cases the final concentration was 10 -Bmoll-I) was observed.
S-(2-Tert-butyloxycarbonylethyl)homocysteine
Homocysteine (2'0 g) was dissolved in liquid ammonia (tOO ml) and reduced with metallic sodium until a blue color persisted for 5 min. The solution was decolorized with ammonium chloride and tert-butyl 3-chloropropanoate (2'8 g) was added. The solution was evaporated over 1 h by a stream of nitrogen and dried ill vacuo. The residue was dissolved in water (60 ml) and extracted with ethyl acetate (2 X 30 ml). The aqueous layer was cooled to DoC and placed on a Dowex 50 column (5 X 5 ern, H +-cycle}. The Dowex 50 was washed until neutral and the product was eluted with 5% ammonia. The solution was evaporated to give 3'85 g (97%) of a powder. Nr .r:-Tert-butyloxycarbonyl-S-(2-tert-butyIoxycarb 0 nylethyljhomocystei ne Dicyclohexylammonium Salt S-(2-Tert-butyloxycarbonylethyl)homocysteine (3'8 g) was dissolved in water (130 ml) and the pH was adjusted to 10 with 4 moll-I NaOH. To the solution 50 ml of n-butanol was added, followed by 6·2 g of Boc-dicarbonate and the mixture was allowed to stir for I h at room temperature maintaining the pH at to. The solution was diluted with water (120 ml) and extracted with hexane (3 X 30 ml). The aqueous layer was cooled to aoc, acidified with 6 mol l"! Bel to a pH 2, extracted with ethyl acetate (3 X 6P ml), washed with brine (50 ml), .dried with NaZS041 and concentrated. The oily product was dissolved in ethyl acetate, 2·83 ml of dicyclohexylamine was added and the solution was diluted with light petroleum (300 ml) and allowed to stand at DoC,
The crystalline product was filtered and dried ill vacuo to give 6·09 g (77%). M.p. 129-130°C, 
Frog and Lizard Skin Bioassays
The biological activities ofct-MSH and the analogs were determined by their ability to stimulate melanosome dispersion ill vitro in the frog and lizard skin bioassay systems as previously reported 3 3 -35. All the solutions were prepared via serial dilutions from a stock solution ( 
